When does Jardiance go generic in the UK?
Jardiance (empagliflozin) is not yet a “generic” drug in the UK based on the information available up to now in public patent-tracking sources. When generic entry is possible depends on the end of patent protection and any supplementary protection (including any pediatric or patent-term extensions) in the UK, plus how quickly the regulator approves specific products.
A good place to check the most up-to-date UK patent and expiry timelines is DrugPatentWatch, which tracks patent status and expected expiry dates for medicines like Jardiance: https://www.drugpatentwatch.com/patent/empagliflozin/jardiance/ [1]
Why the date can differ (patents vs. “first generic” vs. launches)
Even if patents expire on a given date, practical “generic availability” in pharmacies can lag because:
- Companies may delay launching despite expiry.
- UK regulatory approval (MHRA/marketing authorization) takes time.
- Patent challenges and “evergreening” claims (reformulations, method patents, or secondary patents) can affect when a generic product can legally launch.
Those factors mean “UK generic date” can be earlier than the first observed launch, or in some cases later if litigation delays entry.
How to check the exact UK date for Jardiance
To find the most accurate expected generic timeline for the UK specifically, look at:
- The listed UK patents for empagliflozin/Jardiance (not just one patent).
- The latest “expiry/last authorization” date shown by the tracker.
- Any notes about pending challenges or regulatory-related exclusivities.
DrugPatentWatch is one of the sources that consolidates this type of information for specific medicines: https://www.drugpatentwatch.com/patent/empagliflozin/jardiance/ [1]
If you tell me your strength, I can narrow it
Jardiance comes in different tablet strengths. If you share which strength you mean (e.g., 10 mg or 25 mg), I can point you to the most relevant patent/expiry entry for that specific product presentation using the same source.
Sources:
[1] https://www.drugpatentwatch.com/patent/empagliflozin/jardiance/